BWX Technologies Up Nearly 100% in a Year, Now Announces Major Acquisition — Is the Nuclear Rally Just Getting Started?

BWX Technologies (BWXT) has announced the acquisition of Precision Components Group (PCG), a U.S. commercial nuclear manufacturing company. Commercial segment revenue surged 121% year-over-year in Q1 2026, while the stock has gained approximately 100% over the past twelve months.

When investors scan for nuclear energy stocks, names like Oklo (OKLO) and NuScale Power (SMR) tend to dominate the conversation with their small modular reactor narratives. But there is a quieter name steadily gaining ground: BWX Technologies (BWXT). No pure-play nuclear story, no flashy SMR roadshow — just a profitable, dividend-paying business growing in the middle of a nuclear renaissance.

The Acquisition: Expanding U.S. Commercial Nuclear Capacity

BWXT announced the acquisition of Precision Components Group, a U.S. commercial nuclear components manufacturer. The company said the deal will "establish additional U.S. commercial nuclear production capacity to serve growing domestic demand." PCG generated $125 million in revenue in 2025. Regulatory approval is pending.

We will establish additional U.S. commercial nuclear production capacity to serve growing domestic demand.

BWX Technologies

The Numbers Behind the Nuclear Renaissance

BWXT generated $3.2 billion in total revenue for 2025, with $2.3 billion coming from government and defense nuclear operations. Its commercial segment — covering nuclear components, fuel handling, and medical sales — grew 63% from $524 million in 2024 to $853 million in 2025. In Q1 2026, commercial revenue accelerated further to $284 million, up 121% year-over-year.

• FY2025 total revenue: $3.2B (government $2.3B / commercial $853M)
• Commercial segment 2025 growth: +63%
• Q1 2026 commercial revenue: $284M (+121% YoY)
• FY2025 net income: ~$329M
• Backlog: $7.3B total ($5.5B government)

Positioned Across the Nuclear Energy Ecosystem

BWXT spans the nuclear value chain from reactor pressure vessel manufacturing to nuclear medicine, fuel handling, and field engineering services. The company is also the contracted manufacturer of the reactor pressure vessel for the SMR being co-developed by GE Vernova (GEV) and Hitachi. That breadth means BWXT captures the benefits of the nuclear renaissance across more segments than a pure-play startup.

Valuation and Risks

Shares have gained roughly 100% over the past twelve months. With a $19 billion market cap, BWXT screens expensive on traditional valuation metrics. The stock trades about 15% below its 52-week high of $241.82, with a dividend yield of 0.5%. With over 70% of revenue tied to government contracts, budget cuts or policy shifts remain a real risk.

That said, as AI-driven power demand sustains the nuclear renaissance, the combination of stable government contracts and a rapidly scaling commercial segment makes BWXT an under-the-radar beneficiary worth watching in a market where the obvious nuclear plays often carry far more risk.